• 02 Mar 18

Executive interview - VolitionRX reports their Full Year 2017 Earnings

Executive interview - VolitionRX reports their Full Year 2017 Earnings

VOLITIONRX | VNRX | 0 0 0%
Follow Company Follow Company

    • 105 views

 

Enjoying this article?

Get a £25 credit by sharing with your friends and colleagues via the share buttons below. Each new subscriber gets a 10% discount and you get a free month off your bill every time.


Don't worry, if you're a Lite-Access/Free user we save all your credits for the day you decide to fully subscribe.


 

Executive interview - VolitionRX discusses Q319 results and provides a business update

Companies: VOLITIONRX

Executive interview - Volition Rx

Companies: VOLITIONRX

Executive interview - VolitionRX

Companies: VOLITIONRX

Executive interview - VolitionRx

Companies: VOLITIONRX

Executive Interview - VolitionRx

Companies: VOLITIONRX

VolitionRx Limited Announces Interim Results from 680-Subject Clinical Trial in Colorectal Cancer

Companies: VOLITIONRX

Copyright © 2019 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top